Merck increases focus on ophthalmology market with $430M acquisition of Inspire
This article was originally published in Scrip
Executive Summary
Merck & Co has agreed to buy Inspire Pharmaceuticals, which markets several approved eye care products, for about $430 million, as it bids to expand in the ophthalmological area.